A Virtual Event – San Francisco, CA
This master lecture series will provide the most up-to-date, practical information on the management of breast cancer, lung cancer, gastrointestinal, genitourinary, and melanoma in 2021. Immunotherapy and target therapies will be discussed in personalized treatments, and the latest clinical data impacting the management of these cancers. We will discuss the most current data in GI, GU (PARP Inhibitors), Melanoma (Immunotherapy/BRAF), Lung (RET/MET/VEGFR2), and breast cancer (HER2 P13K/Akt/TROP2).
Cutting-edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses, and management plan options for their patients.
For complete conference details, hotel and registration information please visit MLS San Francisco